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Abstract
Background: Prox1, the vertebrate homolog of prospero in Drosophila melanogaster, is a divergent
homeogene that regulates cell proliferation, fate determination and differentiation during
vertebrate embryonic development.
Results: Here we report that, in zebrafish, prox1 is widely expressed in several districts of the
Central Nervous System (CNS). Specifically, we evidenced prox1 expression in a group of neurons,
already positive for otp1, located in the hypothalamus at the level of the posterior tuberculum (PT).
Prox1 knock-down determines the severe loss of hypothalamic catecholaminergic (CA) neurons,
identified by tyrosine hydroxylase (TH) expression, and the synergistic prox1/otp1 overexpression
induces the appearance of hypothalamic supernumerary TH-positive neurons and ectopic TH-
positive cells on the yolk epitelium.
Conclusion: Our findings indicate that prox1 activity is crucial for the proper development of the
otp1-positive hypothalamic neuronal precursors to their terminal CA phenotype.
Background
The catecholaminergic neurons of the CNS of vertebrates
participate in a wide variety of tasks, including motor
coordination, mood regulation, and cognitive function,
among others. Neurotransmitters catecholamines (CA),
namely Dopamine (DA), Adrenaline (AD), and
Noradrenaline (NA), are neuroactive molecules that exert
strong influence on vertebrates behavior [1] and serve a
variety of central and peripheral functions [2].
Embryological studies indicate that several extracellular
signals, as Hedgehog and FGF, are vital to define the
development of the prosencephalic CA neurons [3-7]. The
homeodomain transcription factor Orthopedia (Otp),
regulated by such signaling pathways [8], is crucial in
restricting the fate of multiple classes of secreting neurons
in the neuroendocrine hypothalamus of vertebrates
[9,10]. Specifically, Otp is required for the correct differ-
entiation of the CA neurons positioned in the zebrafish
Posterior Tuberculum (PT) and hypothalamus [8,11].
Despite all these evidences, the role of specific transcrip-
tion factors leading to the proper differentiation of the
hypothalamic CA neurons remains largely unclear [7].
Prox1 homeobox gene is the vertebrate homologous of
prospero  in  Drosophila melanogaster. During Drosophila
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embryonic development, prospero is expressed in neuronal
precursors and determines the neuronal/glial fate of sib-
ling cells [12,13]. prospero/Prox1's high level of homology
pinpoints possible functional conservation through evo-
lution, suggesting Prox1 involvement in vertebrate cell fate
determination. Indeed, also during murine brain develop-
ment, Prox1 is expressed in most of the locations in which
neurogenesis and glial formation occur during middle
and late prenatal and postnatal stages, as the subventricu-
lar zone, several regions of the prethalamus and hypotha-
lamus, the cerebellum, and the hippocampus [14].
Here, we demonstrated that, in zebrafish, prox1 is widely
expressed in the developing CNS, and one of its expres-
sion domains is located in the area corresponding to the
ventral part of the PT and the adjacent hypothalamic dis-
trict, the area hosting the cluster of CA neurons positive
for otp1 expression [8,11]. Moreover, we took advantage
of the zebrafish animal model to investigate the in vivo
influence of prox1 on hypothalamic CA neuronal develop-
ment by means of morpholino- and mRNA- loss and gain
of function methodologies.
We provide evidence that prox1 is required for the devel-
opment of hypothalamic neuronal progenitors into
mature CA neurons.
Results and discussion
Homeobox genes are expressed in a temporal and spatial
restricted manner and play crucial roles for cell type spec-
ification [15,16]. Zebrafish prox1 is a divergent homeodo-
main transcription factor whose homologues in
Drosophila and mice regulate cell proliferation, fate deter-
mination and differentiation in CNS and sensory tissues
[17-21]. Noteworthingly, during murine brain develop-
ment, Prox1 is also expressed in the hypothalamus [14],
where several CA neurons differentiate.
Spatio-temporal expression of prox1 during 
embryogenesis
Previously published immunostaining analysis of the
Prox1 expression pattern revealed that the gene is active in
several zebrafish embryonic districts [22]. To explore the
role of prox1 during zebrafish CNS development, we first
performed a more detailed characterization of prox1
expression during embryogenesis and in adult organs by
means of RT-PCR (Fig. 1). We detected the presence of
prox1  transcript at all stages analyzed, including the
zygote, indicating that prox1 is also maternally expressed
(Fig. 1A). Furthermore, we report prox1 expression in the
adult brain, eyes, and in non-neuroectodermal territories
(testis, ovary, gills, gut, liver) (Fig. 1B). The spatial and
temporal distribution of prox1 transcripts was then exam-
ined by whole mount in situ hybridization (WISH), fol-
lowing standard protocols, with digoxigenin- and
fluorescein-UTP-labeled probes [23]. At all stages ana-
lyzed, from 1–2 cell stage to 5 days post fertilization (dpf),
zebrafish  prox1  expression analysis confirms and
improves previous immunostaining results [22]. From an
evolutionary point of view, the striking resemblance of
the prox1 expression pattern among vertebrates strongly
suggests a conserved role for the gene during evolution.
Although RT-PCR revealed the presence of maternal and
zygotic transcripts, prox1 mRNA is first detectable through
WISH around the 2 somites (s) stage in the ectodermic
region corresponding to the otic placode (Fig. 1C). At 15
s stage, prox1 is also expressed in the lens placode (Fig.
1D) and in the first formed somites (Fig. 1D, inset). At 24
hours post fertilization (hpf), prox1 expression persists in
the lens (Fig. 1E,F) and in the adaxial cells (see Additional
file 1) that will later differentiate in slow muscle fibers
[24]. Moreover, two distinct bilateral prox1 signals appear
on each side of the midline, at the rostral end of the neural
tube, in a region corresponding to the hypothalamus (Fig.
1E). At the same stage, strong prox1  expression signals
define the pituitary, the pretectal segment (prosomere 1,
according to Rink and Wullimann [25]), and each hind-
brain neuromeric segment (rhombomeres), where prox1
expression is visible in segmentally arranged clusters of
cells (Fig. 1E). Additionally, prox1 signals are detectable in
the liver and the posterior lateral line primordium (PLLP)
(Fig. 1G). Starting from 48 hpf, further signals appear in
the retina, pancreas (Fig. 1H), and in the cephalic ganglia
(see Additional file 2). At 7 dpf, when the retinal's layers
are fully differentiated, prox1 signal is detectable specifi-
cally in the inner nuclear layer, as previously shown in
other vertebrates [20], and in the pretectal nuclei (Fig. 1I).
In this work, we focused our attention on prox1 role dur-
ing zebrafish hypothalamic development.
prox1 is required for the development of a group of 
hypothalamic CA neurons
The determination of the neurotransmitter phenotype is
an important aspect of neuronal differentiation. Degener-
ation of substantia nigra DA neurons in humans is a hall-
mark of Parkinson's disease, and the malfunction of CA
neurons in other brain regions is implicated in psychiatric
disorders and neuroendocrine dysregulation [26-28].
In zebrafish, a detailed characterization of the CA neuro-
transmitter pathway makes this organism a favorite model
to address the ontogeny of the vertebrate neurosecretory
system [8,11,29-31]. TH-expressing CA neurons are pri-
marily located in the anterior dorsal telencephalon and
hypothalamus of the developing forebrain, with a few
additional neurons present near the postoptic commis-
sure and pretectum region [29]. 36 hpf embryos hybrid-
ized with prox1 mRNA probe and immunostained with
TH antibody show that prox1 transcript is present in close
proximity to the most caudal posterior tubercular and theBMC Developmental Biology 2008, 8:27 http://www.biomedcentral.com/1471-213X/8/27
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adjacent hypothalamic TH-expressing cells, with partial
overlap of the two signals (Fig. 2A,E,I). To determine
whether prox1 is required for CA neuron development, we
knocked-down the protein level by injecting 4 ng/embryo
of a specific ATG-targeted morpholino oligonucleotide
(prox1 MO) [32,33]. Abrogation of Prox1 function leads
to a severe loss of neurons in the hypothalamic portion of
the PT/hypothalamic CA cluster (at 36 hpf, 70% of the
embryos showing no or few TH-positive cells in this area,
n = 150) (Fig. 2B,C,F,G). This defect is already evident at
24 hpf (see Additional file 3) and persists later during
development, as shown by TH immunostaining at 48 hpf
(see Additional file 3). The overall architecture of the ven-
tral diencephalon was not affected in prox1 MO injected
embryos, as suggested by the normal expression of shh
(see Additional file 4). Therefore, we concluded that the
decrease in the number of CA cells is not determined by
an alteration in the patterning of the hypothalamus. We
also analyzed the th expression levels in prox1 MO injected
embryos by means of quantitative real time RT-PCR. The
th specific mRNA level was about five-fold decreased in
prox1  MO injected embryos when compared to the th
expression in control embryos injected with the standard
control morpholino oligonucleotide (stdr MO) (Fig. 2L),
confirming the immunohistochemical analysis reported
above. To demonstrate that the reduction of TH positive
cells in the hypothalamus of the embryos is specifically
caused by the MO-induced abrogation of Prox1 function,
prox1 temporal and spatial expression pattern analyzed by RT-PCR and in situ hybridization Figure 1
prox1 temporal and spatial expression pattern analyzed by RT-PCR and in situ hybridization. (A) RT-PCR per-
formed on different embryonic stages: 1–2 cells stage (lane 1), 30% epiboly (lane 2), 50% epiboly (lane 3), 80% epiboly (lane 4), 
tail bud (lane 5), 8 somites (lane 6), 15 somites (lane 7), 24 hpf (lane 8), 72 hpf (lane 9), 5 dpf (lane 10) and negative control (lane 
11) in the absence of cDNA. (B) RT-PCR performed on different adult organs: DNA ladder (L), testis (lane 1), overy (lane 2), 
gills (lane 3), gut (lane 4), eye (lane 5), brain (lane 6) and liver (lane 7). Arrowhead indicates the size of the prox1-specific PCR 
product (620 bp). (C-I) prox1 WISH (C) the first signals appeared at 2 s in the otic placode (arrowhead). (D) at 15 s the signal is 
detected in the lens placode (arrowhead), and somites (inset). (E) at 24 hpf prox1 is expressed the hypothalamus (asterisc), the 
pituitary (black arrowhead), the pretectal segment (prosomere 1) (white arrow), as well as segmentally arranged cells of the 
hindbrain (black arrow). (F) transverse section through the forebrain of a 24 hpf stage zebrafish embryo shows the signal in the 
lens (black arrowhead). (G) at 24 hpf additional prox1 signals are present in the liver primordium (arrow), and posterior lateral 
line primordium (arrowheads). (H) later during development, (48 hpf) prox1 expression is detected in distinct domains in the 
liver (arrow) and pancreas (arrowhead), while a further signal appeares in the retina (white arrow). (I) transverse section 
through the forebrain of a 7 dpf stage zebrafish larva shows the signals in the retina inner nuclear layer (arrow) and in the pre-
tectal nuclei (arrowhead). (C,E) Lateral views are shown. (D) Frontal view is shown. (G,H) Dorsal views are shown. Anterior is 
always to the left. Scale bars indicate 100 μm (A,B,C,D,G,H,I) or 200 μm (E,F).BMC Developmental Biology 2008, 8:27 http://www.biomedcentral.com/1471-213X/8/27
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we performed a rescue experiment by coinjecting the
embryos with 4 ng/embryo of prox1  MO and 400 pg/
embryo of prox1 mRNA (Fig. 2D,H). 80% of the embryos
at 36 hpf (n = 120) rescued the normal phenotype and
displayed a proper number of hypothalamic TH-positive
neurons (Fig. 2D,H). On the other hand, overexpression
of prox1 alone does not lead to supernumerary CA neu-
rons in the ventral diencephalon, nor determines ectopic
CA neuron formation, confirming that prox1 functions are
required for the proper development of the TH phenotype
in a subpopulation of hypothalamic neurons, but are not
sufficient to determine the appearance of supernumerary
or ectopic TH-expressing cells. Interestingly, prox1 overex-
pression induces a slight increase of th mRNA levels, as
detectable by means of quantitative real time RT-PCR only
(data not shown); further investigations are necessary to
elucidate this aspect that might reflect the ability of prox1
to directly modulate th expression in those few cells where
the two genes are coexpressed.
In order to address whether prox1 is involved in neuro-
genesis processes, we analyzed the expression pattern of
the proneural gene ngn1 [34]. ngn1 expression domains
resulted unaffected in prox1 MO injected embryos, allow-
ing us to conclude that loss of CA neurons in the hypoth-
alamus of prox1 MO injected embryos is not caused by
alteration in neurogenesis (see Additional file 5). Moreo-
ver, in order to address this issue, we analyzed the devel-
opment of other neurotransmitter-producing neurons.
Specifically, the neighboring serotonergic neurons
prox1 is required for the development of CA neurons in the hypothalamus Figure 2
prox1 is required for the development of CA neurons in the hypothalamus. Anterior is left in all panels except (A), 
frontal view. Dorsal is up, except for (B,C,D), dorsal view. Eyes or lens have been removed for better lateral viewing. (A,E,I) 
prox1 WISH combined with TH immunohistochemistry. Anti-TH antibody labels the PT and hypothalamic CA neurons at 36 
hpf. Colabelling with prox1 is evident in a fraction of TH-positive neuroblasts in the hypothalamus (arrowheads), as also con-
firmed by the longitudinal section of the embryo (I). (C,G) microinjection of prox1 MO lowers the number of TH-labelled CA 
neurons in the hypothalamus in comparison to standard control injected embryos (B,F). (D,H) coinjection of prox1 mRNA and 
prox1 MO rescued the morphant phenotype. (L) Quantitative real time RT-PCR. TH-specific mRNA is almost five-fold 
decreased following prox1 MO injection. The result represents at least three independent experiments, and 18S was used as an 
internal control. The following abbreviations are used: posterior tuberculum (PT), pituitary (Pit), hypothalamus (Hy), standard 
control morpholino oligonucleotide (stdr MO). Scale bars indicate 10 μm (B,F,I) or 20 μm (A,E).BMC Developmental Biology 2008, 8:27 http://www.biomedcentral.com/1471-213X/8/27
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appeared only slightly affected by Prox1 ablation in com-
parison to the most relevant effects we observed in the CA
population (see Additional file 6). However, our descrip-
tion of prox1 effects on CA neuron development cannot
rule out its potential involvement in the differentiation or
fate determination of other neuronal types.
prox1 functions are required for proper otp1 and TH 
phenotypes in the hypothalamic area
To further investigate the roles of prox1 in the hypotha-
lamic CA neurons development, we showed that prox1 is
also able to influence the otp1 (otpb) phenotype in
hypothalamic neurons. As previously reported by our
group [8], zebrafish otp1 contributes to the specification
and differentiation of DA diencephalic neurons in the PT
and the hypothalamus. In search of possible relationships
between prox1 and otp1 in determining the TH phenotype,
we performed a double WISH that evidenced the coex-
pression of the two genes in the hypothalamus (Fig.
3A,B). We also demonstrated that some of these prox1/
otp1-positive cells are also positive for TH (Fig. 3B,B'), sup-
porting the hypothesis that the coexpression of the two
genes influences the development of the final TH pheno-
type. Injection of the embryos with otp1  MO or otp1
mRNA does not result in significant changes in prox1
expression pattern at 24 and 48 hpf (data not shown). On
the other hand, a MO-mediated reduction of Prox1 levels
determines significant modifications in otp1 expression
pattern in the hypothalamic area, while otp1 expression in
the rhombomeres resulted unperturbed. Specifically, the
injection of prox1 MO causes the decrease of otp1-positive
neurons in the hypothalamus at 48 hpf in comparison
with embryos injected with the stdr MO (Fig. 3C,D). On
the contrary, prox1 overexpression does not modify otp1
hypothalamic domains, nor determines otp1  ectopic
expression (data not shown). Our findings indicate that
prox1 is necessary, but not sufficient, to the proper otp1
phenotype in the hypothalamic area. Interestingly, otp1
appearance in the hypothalamus [8] precedes the onset of
prox1 expression in this area, suggesting that prox1 is not
involved in the activation of otp1 transcription. Rather,
prox1 activity might be vital to control the switch of the
otp1-positive cells towards their final TH fate. The hypoth-
esis is supported by the evidence that prox1 MO and otp1
synthetic mRNA coinjection did not restore the normal
TH phenotype (see Additional file 7). Thus, lack of Prox1
might impede further neuronal differentiation, causing
apoptosis or cell misspecification, with consequent loss of
prox1 functions are required for proper otp1 and TH phenotypes in the hypothalamic area Figure 3
prox1 functions are required for proper otp1 and TH phenotypes in the hypothalamic area. Anterior is left, dorsal 
is up except for (B,B'), dorsal view. In (A) eyes have been removed. (A) prox1/otp1 double WISH. Double staining of prox1 (blue) 
and otp1 (red) mRNAs at 36 hpf stage reveals that otp1 and prox1 colocalize in the hypothalamus. (B,B') 36 hpf prox1/otp1 dou-
ble WISH combined with TH immunohistochemistry. (B) A group of prox1/otp1-positive cells in the hypothalamus are also pos-
itive (B') for TH; for better orientation, some of these cells have been numbered (1–5) and indicated by black (B) and white (B') 
arrowheads, respectively. otp1 hypothalamic expression in (C) standard control morpholino and (D) prox1 MO injected 
embryos at 48 hpf. The following abbreviations are used: posterior tuberculum (PT), preoptic area (PO), standard control mor-
pholino oligonucleotide (stdr MO). The following abbreviations are used: posterior tuberculum (PT), preoptic area (PO), pitui-
tary (Pit), hypothalamus (Hy). Scale bars indicate 20 μm (A,B,B') or 30 μm (C,D).BMC Developmental Biology 2008, 8:27 http://www.biomedcentral.com/1471-213X/8/27
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otp1 and th expression. In order to discriminate between
these two possibilities, we performed a TUNEL assay on
prox1 MO injected embryos at 24 hpf (see Additional file
8) and at 36 hpf (data not shown). The level of apoptosis
is not increased by Prox1 knock-down, suggesting that the
lower number of otp1-positive hypothalamic neurons
might be determined by misspecification events rather
than apoptosis. Interestingly, otp1 is expressed in those
cells already switched towards a more differentiated state,
such as early postmitotic DA precursors, as well as newly
specified and mature DA cells [8,11]. Thus, according to
the wealth of literature data pinpointing prox1 as a key
player in the passage from proliferation to differentiation
[20,21,35], prox1 in the hypothalamus might drive the
cells towards differentiative processes, leading to the ter-
minal TH phenotype of those precursors committed to a
CA phenotype by the expression of otp1.
Overexpression of prox1 and otp1 together leads to 
supernumerary CA neurons in the ventral diencephalon 
and TH positive cells on the yolk surface
To verify whether prox1 and otp1 together have an impact
on the CA phenotype in the hypothalamus, we coinjected
their specific mRNAs at a concentration of 450 and 300
pg/embryo, respectively, and stained the embryos for TH
at 36 hpf. As reported above, the injection of prox1 mRNA
alone did not increase the number of hypothalamic CA
neurons, nor did single 300 pg/embryo otp1 mRNA injec-
tion (data not shown). Comparable results were obtained
injecting 450 pg/embryo of the GFP mRNA as control
(Fig. 4). The most numerous class in the group of control
embryos presented 8 CA hypothalamic neurons, and only
3 embryos presented more than 11 TH hypothalamic pos-
itive cells. On the other hand, the most numerous class in
the group of the overexpressed prox1/otp1 embryos (n =
64) presented 10 CA neurons, and 20 embryos showed
more than 11 TH hypothalamic positive cells (Fig. 4A,B),
pointing out the synergistic effect of the prox1/otp1 coex-
pression on the CA phenotype establishment. Remarka-
bly, we also evidenced that prox1/otp1 coinjection induces
TH positive cells on the yolk surface (Fig. 4D,E), while
these ectopic cells were never observed in control (GFP) or
single (prox1 or otp1) injected embryos (Fig. 4C). Note-
worthy, in the CNS, the overproduction of TH positive
cells induced by coinjection was detected in the hypotha-
lamus, suggesting that prox1 and otp1 genes require addi-
tional factors, present in the ventral diencephalon, to
induce the TH phenotype. Thus, we demonstrated that the
coexpression of prox1  and  otp1  determines a higher
Synergistic prox1/otp1 overexpression induces the appearance of hypothalamic supernumerary TH-positive neurons and  ectopic TH-positive cells on the yolk surface ectoderm Figure 4
Synergistic prox1/otp1 overexpression induces the appearance of hypothalamic supernumerary TH-positive 
neurons and ectopic TH-positive cells on the yolk surface ectoderm. Lateral view, anterior is left and dorsal is up. 
(A,B) Distribution of TH positive cells in control and overexpressed prox1/otp1 embryos at 36 hpf. (A) The most numerous class 
in the group of GFP mRNA injected control embryos presented 8 CA hypothalamic neurons, and only 3 embryos presented 
more than 11 TH hypothalamic positive cells (n = 54). (B) The most numerous class in the group of the overexpressed prox1/
otp1 embryos (n = 64) presented 10 CA neurons, and 20 embryos showed more than 11 TH hypothalamic positive cells. (C,D) 
Immunostaining with TH antibody shows ectopic TH positive cells on the yolk surface ectoderm of prox1/otp1 double injected 
embryos (arrowheads), while these cells are not present on the yolk of control embryos. (E) Ectopic TH positive cell on the 
yolk surface ectoderm. Scale bars indicate 50 μm.BMC Developmental Biology 2008, 8:27 http://www.biomedcentral.com/1471-213X/8/27
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number of CA neurons in the hypothalamus and induces
ectopic TH positive cells in non-neuroectodermal regions.
Conclusion
In conclusion, we highlight for the first time the role of
prox1 in the proper development of the CA neurons in the
ventral diencephalon. Moreover, we provide evidence of
regulatory links between prox1 and otp1 genes in defining
the terminal TH phenotype in the hypothalamus. The
identification of prox1 as a key component in the differen-
tiation of hypothalamic CA neurons will help in clarifying
the developmental bases of several human behavioral
aspects as well as pathologies such as addictions and Par-
kinson's disease.
Methods
Animals
Breeding wild type fish of the AB strain were maintained
at 28°C on a 14 h light/10 h dark cycle. Embryos were col-
lected by natural spawning, staged according to Kimmel
and colleagues [36], and raised at 28°C in fish water
(Instant Ocean, 0,1% Methylene Blue) in Petri dishes. We
express the embryonic ages in somites (s), hours post fer-
tilization (hpf) and days post fertilization (dpf).
RT-PCR
Total RNA from 17 samples (an average of 30 embryos per
sample) corresponding to 10 different developmental
stage embryos (1–2 cells, 30% epiboly, 50% epiboly, 80%
epiboly, tailbud, 8 s, 15 s, 24 hpf, 72 hpf, and 5 dpf) and
7 adult organs (testis, ovary, gills, gut, eyes, brain, and
liver) was extracted with the TOTALLY RNA isolation kit
(Ambion), treated with RQ1 RNase-Free DNase
(Promega) and oligo(dT)-reverse transcribed using Super-
Script II RT (Invitrogen), according to manufacturers'
instructions. The following primers were used for PCR
reactions:  prox1_sense 5'-ACCTCAGCCACCATCGTTC-
CATC-3' and prox1_antisense 5'-CACTATTCATGCA-
GAAGCTCCTGC-3'. PCR products were loaded and
resolved onto 2% agarose gels.
In situ hybridization and immunohistochemistry
Whole mount in situ hybridization (WISH), was carried
out as described [23] on embryos fixed for 2 h in 4% para-
formaldehyde/phosphate buffered saline, then rinsed
with PBS-Tween, dehydrated in 100% methanol and
stored at -20°C until processed for WISH [37]. Antisense
riboprobes were previously in vitro labelled with modified
nucleotides (i.e. digoxigenin, fluorescin, Roche). For his-
tological sections, stained embryos were re-fixed in 4%
PFA, dehydrated and stored in methanol, wax embedded
and sectioned (5 μm). For immunohistochemistry,
embryos were exposed to rabbit anti-Tyrosine Hydroxilase
(anti-TH) (Chemicon), or rabbit anti-Serotonin (anti-
5HT) (Chemicon), then treated with biotinylated or fluo-
rescent secondary antibody (Vector Laboratories).
Quantitative real time RT-PCR
Reverse transcriptions (RTs) were performed using 2 μg of
DNase treated (DNA-free™, Ambion Inc) total RNA in
presence of random hexamers (Invitrogen™) and Super-
Script II reverse transcriptase (Invitrogen™). Real-time
PCRs were carried out in a total volume of 15 μl contain-
ing 1× iQ SYBR Green Super Mix (BioRad), using 1 μl of
the RT reaction. PCRs were performed using the BioRad
iCycler iQ Real Time Detection System (BioRad Laborato-
ries). For normalization purposes, 18S ribosomal RNA
level was tested in parallel with the gene of interest. The
following primers were used:
th1_sense 5'-ATGCCATCATCTTGTCACCA-3'
th1_antisense 5'-GGCAATGTCTCCGATCATCT-3';
18S_sense 5'-ACCTCACTAAACCATCCAATC-3'
18S_antisense 5'-AGGAATTCCCAGTAAGCGCA-3'.
TUNEL staining
For TUNEL assay, 24 and 36 hpf embryos were fixed with
4% PFA for 2 h at room temperature. Embryos were per-
meabilized with methanol at -20°C and washed twice
with PBC (0.001% Triton ×-100, 0.1% sodium citrate in
PBS) for 10 minutes. Labeling for apoptotic cells was per-
formed using In situ Cell Death Detection Kit (Roche).
The embryos were incubated at 37°C for 1 h, washed and
mounted for fluorescent microscopic imaging.
Injections
Injections were carried out on 1- to 2-cell stage embryos;
the dye tracer rhodamine dextran was also coinjected.
Synthetic capped prox1  or  otp1  mRNA were injected
repeatedly (n > 3) at concentrations of 450 pg and 300 pg
per embryo, respectively. Double mRNA injection was
performed with 450 pg prox1  mRNA and 300 pg otp1
mRNA per embryo; 450 pg of synthetic capped GFP
mRNA was injected as control. To repress prox1 mRNA
translation, an ATG-targeting morpholino was synthe-
sized (Gene Tools, LLC): 5'-ATGTGCTGTCATGGTCAG-
GCATCAC-3' [32,33]. prox1  MO was used at the
concentration of 1 pmole in 1× Danieau buffer (pH 7,6)
as previously reported [38]. To repress otp1 mRNA trans-
lation, an ATG-targeting morpholino was designed (Gene
Tools, LLC): 5'-CCAAGAGGTCGGCATGAGAGAGCAT-3'
[8]. otp1 MO was used at the concentration of 0,7 pmole.
As control we injected a standard control morpholino oli-
gonucleotide (stdr MO). Double prox1 MO/otp1 mRNA
was performed with 1 pmole of MO and 300 pg of syn-
thetic mRNA per embryo.BMC Developmental Biology 2008, 8:27 http://www.biomedcentral.com/1471-213X/8/27
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At 24 and 48 hpf the TH-labelled cells in the hypothalamic/PT area are 
reduced in number in the prox1 MO injected embryos (B,D) when com-
pared to the control embryos injected with stdr MO (A,C). The following 
abbreviation is used: posterior tuberculum (PT). Scale bar indicates 10 
μm.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-8-27-S3.tiff]
Additional file 4
shh expression pattern in the CNS of stdr MO and prox1 MO injected 
embryos. Anterior is left and dorsal is up in all panels. (A) 24 hpf embryo 
injected with standard control morpholino oligonucleotide. (B) 24 hpf 
embryo injected with prox1 MO. The overall brain patterning of the ven-
tral diencephalon is not affected in prox1 MO injected embryos, as sug-
gested by the normal expression of shh that we used as marker of proper 
differentiation of the ventral diencephalon. The following abbreviations 
are used: standard control morpholino oligonucleotide (stdr MO). Scale 
bars indicate 50 μm.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-8-27-S4.tiff]
Additional file 5
ngn1 expression pattern in the CNS of stdr MO and prox1 MO injected 
embryos. Anterior is left and dorsal is up in all panels. (A) 24 hpf embryo 
injected with standard control morpholino oligonucleotide. (B) 24 hpf 
embryo injected with prox1 MO. Neurogenesis is not disturbed in prox1 
MO injected embryos as shown by normal ngn1 hypothalamic expression. 
The following abbreviation is used: standard control morpholino oligonu-
cleotide (stdr MO). Scale bars indicate 50 μm.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-8-27-S5.tiff]
Additional file 6
5HT expression in prox1 MO injected embryos. Ventral view in all pan-
els. Anterior is up. Anti-5HT antibody labels the hypothalamic serotoner-
gic neurons at 48 hpf. (B) microinjection of prox1 MO does not 
significantly lower the number of 5HT-labelled neurons in the hypothala-
mus in comparison to the 48 hpf embryos injected with the same concen-
tration of standard control morpholino oligonucleotide (A). Scale bar 
indicates 10 μm.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-8-27-S6.tiff]
Additional file 7
TH expression in prox1 MO/otp1 mRNA coinjected embryos. Ventral 
view in all panels. Anterior is up. Anti-TH antibody labels the PT and 
hypothalamic CA neurons at 36 hpf (boxed regions). (B) microinjection 
of prox1 MO lowers the number of TH-labelled CA neurons in the 
hypothalamus in comparison to the 36 hpf embryos injected with the same 
concentration of standard control morpholino oligonucleotide (A). (C) 
coinjection of prox1 MO and otp1 synthetic mRNA did not restore the 
normal TH phenotype. Scale bar indicates 20 μm.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-8-27-S7.tiff]
Additional file 8
prox1 MO injected embryos do not show increased apoptosis. Lateral view 
in all panels. Anterior is to the left, and dorsal is up. Apoptosis in 24 hpf 
embryos has been evaluated by means of TUNEL assay. (B) prox1 MO 
injected embryos do not show increases in apoptosis when compared to the 
control embryos injected with stdr MO (A). The white drawing indicates 
the profile of the embryos. The following abbreviations are used: standard 
control morpholino oligonucleotide (stdr MO), eye (E), hypothalamus 
(Hy), yolk (y). Scale bar indicates 50 μm.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
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